Last checked at 30 Jun 2021 12:03
30 June 2021
Eden Research Plc
("Eden" or "Company")
Result of AGM
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, is pleased to announce that, at the Annual General Meeting ("AGM") of Eden held today at 12.00pm at 67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RQ, all the resolutions were duly passed.
For further information contact:
Eden Research plc | www.edenresearch.com |
Sean SmithAlex Abrey | 01285 359 555 |
Cenkos Securities plc (Nominated advisor and broker) | |
Giles Balleny / Camilla Hume/ Mark Connelly (corporate finance)Michael Johnson (sales) | 020 7397 8900 |
Hawthorn Advisors (Financial PR) | |
Lorna Cobbett / Victoria Ainsworth | eden@hawthornadvisors.com |
Notes to Editors:
Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden's Sustaine® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.
Eden has numerous patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. Eden was admitted to trading on AIM in May 2012.
For more information about Eden, please visit: www.edenresearch.com.
ENDS